Perioperative Management of Antiplatelet-Drugs in Cardiac Surgery

Author(s): Raquel Ferrandis, Juan V. Llau, Ana Mugarra

Journal Name: Current Cardiology Reviews

Volume 5 , Issue 2 , 2009

Become EABM
Become Reviewer


The management of coronary patients scheduled for a coronary artery bypass grafting (CABG), who are receiving one or more antiplatelet drugs, is plenty of controversies. It has been shown that withdrawal of antiplatelet drugs is associated with an increased risk of a thrombotic event, but surgery under an altered platelet function also means an increased risk of bleeding in the perioperative period. Because of the conflict recommendations, this review article tries to evaluate the outcome of different perioperative antiplatelet protocols in patients with coronary artery disease undergoing CABG.

Keywords: Cardiac Surgery, Antiplatelet-Drugs, Perioperative Management, coronary artery disease (CAD), coronary artery bypass grafting (CABG)

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [125 - 132]
Pages: 8
DOI: 10.2174/157340309788166688
Price: $65

Article Metrics

PDF: 2